Sun Pharmaceutical Industries today said merger of Ranbaxy with itself has been 'consummated' following receipt of requisite approvals.

The central bank also approved issue of equity shares of Sun Pharma to the non-resident holders of equity shares of Ranbaxy Laboratories, t...

How Sun Pharma integrates its business will be keenly followed, says Kohli. Merged entity will take some time to derive synergistic benefit...

Ranbaxy Laboratories rose by 2.37% to settle at Rs 720.35 on the BSE. In intra-day trade, it jumped 3.46% to touch 52-week high of Rs 728.

Shares of Ranbaxy Lab & Sun Pharma gained up to 3.5% at close after CCI cleared their long-pending $4-billion merger, though with riders.

The watchdog may have to set up a mechanism to ensure that the company complies with the steps it prescribed after completion of the merger.

Last week, the court had vacated the status quo order it had issued earlier on the merger process between Sun Pharma and Ranbaxy.

The Andhra Pradesh high court on Saturday vacated stay orders it issued last month on the merger of two firms that would create world’s fou...

After hearing the arguments from the counsels of the petitioners, Ranbaxy, Sun Pharma and SEBI, Justice G Chandraiah said he will pronounce...

The court had earlier issued interim orders to maintain status quo with regard to the merger.

Two individual investors alleged that there was heavy trading of Ranbaxy stock before the merger with Sun Pharma was announced on April 6.

The drug maker also said that the petitioners have intermingled two separate issues - insider trading and merger process of Sun Pharma and ...

George Nakayama asked ‘talented’ executives in Ranbaxy Labs to not unduly worry about their prospects in the backdrop of the company gettin...

The $4 billion merger deal of Ranbaxy with Sun Pharma is expected to close by the end of 2014, Japanese drug maker Daiichi Sankyo said.

An investor who is really confident that the deal will go through can buy Ranbaxy shares and pocket the difference when the merger is compl...

Sun Pharma may not have to face surprises emanating from Ranbaxy. There is every likelihood that brand Ranbaxy will see a sunset clause whe...

Sun Pharmaceutical Industries said that it will buy generic drug maker Ranbaxy Laboratories, has hit regulatory snags in its key US market ...